Purpose-driven: Getting critical medication to a child in need
Putting people first is part of how we live our purpose. For these two AmerisourceBergen associates, it meant getting a critical medication to a young cancer patient.
To launch an orphan drug, a manufacturer must overcome unique commercialization challenges, while navigating critical product access scenarios that exist most acutely for small patient populations. Read how one manufacturer ensured that its life-changing therapy would reach patients in need the moment it was first available—and what other manufacturers can learn from this manufacturer’s experiences.
